Science Speaks

News

September 26, 2018

GlobalHealth.png

Science Speaks Notes Slow Progress Against Tuberculosis

With a look at obstacles to accessing the newest tuberculosis treatments in the United States, and the ramifications of global TB data, the global Science Speaks blog highlighted needs for accelerated responses against an ancient disease with:

A report on compassionate use of a drug yet to receive approval from the U.S. Food and Drug Administration: Delamanid delay comes home;

Coverage of the World Health Organization launch of its 2018 Global TB report: WHO 2018 global TB report presented as agenda for UN meeting, commitments.